Meta-analysis of the Rad51 G135C polymorphism on cancer risk.

<p>P-values for ORs; <i>Ph</i> values of Q-test for heterogeneity test; I² refers to the proportion of total variation owing to between-study heterogeneity</p><p>Bold data represent the positive results.</p><p>PB: population based; HB: hospital based; AML: acute myelocytic leukemia; HNC: head and neck cancer</p>*<p>Random-effects model was used when <i>Ph</i> value for heterogeneity test <0.05; otherwise, fix-effects model was used.